Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Arcellx Q2 EPS $(0.51) Beats $(0.55) Estimate, Sales $27.38M Beat $21.75M Estimate

Author: Benzinga Newsdesk | August 08, 2024 04:58pm
Arcellx (NASDAQ:ACLX) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.55) by 7.27 percent. This is a 2 percent decrease over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $27.38 million which beat the analyst consensus estimate of $21.75 million by 25.90 percent. This is a 91.47 percent increase over sales of $14.30 million the same period last year.

Posted In: ACLX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist